Cargando…
Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC
Inflammatory breast cancer (IBC) is an aggressive disease for which the spectrum of preclinical models was rather limited in the past. More recently, novel cell lines and xenografts have been developed. This study evaluates the transcriptome of an extended series of IBC preclinical models and perfor...
Autores principales: | Rypens, Charlotte, Bertucci, François, Finetti, Pascal, Robertson, Fredika, Fernandez, Sandra V., Ueno, Naoto, Woodward, Wendy A., Van Golen, Kenneth, Vermeulen, Peter, Dirix, Luc, Viens, Patrice, Birnbaum, Daniel, Devi, Gayathri R., Cristofanilli, Massimo, Van Laere, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766434/ https://www.ncbi.nlm.nih.gov/pubmed/35042871 http://dx.doi.org/10.1038/s41523-021-00379-6 |
Ejemplares similares
-
Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)()
por: Joglekar-Javadekar, Madhura, et al.
Publicado: (2017) -
Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC
por: Iwase, Toshiaki, et al.
Publicado: (2020) -
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers
por: Bertucci, François, et al.
Publicado: (2020) -
Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10(th) Anniversary Conference
por: Woodward, Wendy A., et al.
Publicado: (2017) -
Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors
por: Bertucci, François, et al.
Publicado: (2021)